To study transcgtosis at the blood-brain barrier (BBB) in Vivo, we used the internal carotid artery perfusion technique in rats. Brain uptake of the 0x26 a n t i -d e n receptor antibody (IgGa) coupled to 5-nm colloidal gold (0x26-Au) was morphologically examined after infusion or perfusion into the carotid artery for 10 min. The brain tissue was subsequently perfusion-fmed with 2% glutaraldehyde. By light microscopy, silver enhancement of Vibratome sections d e d staining of the d tree. Electron microscopy showed binding of gold particles at the luminal plasma membrane of brain capillary endothelia, endocytosis in vesicles (50-100 nm), and particles beyond the abluminal plasma membrane.
Introduction
Evidence has accumulated at the physiological and pharmacologic level that macromolecules are transported through the endothelial cells of the brain microvasculature, which represent the morphological basis of the blood-brain barrier (BBB) (3). by receptormediated or absorption-mediated transcytosis (2). This provides an avenue for the delivery to brain tissue of substances such as hydrophilic peptides, which are otherwise excluded from passage through the BBB. In one approach, "chimeric peptides" are synthesized by the coupling of a non-transportable peptide to a vector, which mediates brain uptake (17) . The recent demonstration of central nervous system pharmacologic dfects in vivo after peripheral administration of neuropeptides, such as vasoactive intestinal polypeptide (1) or nerve growth factor (lo), coupled to the anti-transferrin receptor monoclonal antibody (MAb) 0x26, showed Supported by NIH grant RO1-DAO6748. Part of this study was presented at the 22nd Annual Meeting of the Society for Neuroscience, Anaheim, October 25-30, 1992. Correspondence to: Ulrich Bickcl, c/o W. M. Pardridge, Dept. of Medicine, UCLA School of Medicine, Los Angeles, CA 90024. showed no evidene of brain uptake or binding to endothelium. However, microvessel structures were identifed after silver enhancement of vibratome sections of brain following internal carotid artery infusion of 5-nm colloidal gold conjugates of UPClO (UPC10-Au). The morphologically observed binding of UPC10-Au to brain miaovesscls may be induced by gold conjugation. These studies describe the use of gold conjugates of antibodies to delineate the subcellular pathway involved in aanscgtosis through the BBB. the potential of this strategy of vector-mediated drug delivery. The abundant expression of transferrin receptors on brain microvascular endothelium cells had originally been detected with this antibody (11) . When used as a vector, OX26 can carry molecules at least as large as avidin (64 KD) without significant effect on its permeability at the BBB (32).
At the morphological and particularly at the ultrastructural level, the process of transcytosis at the BBB is still poorly characterized. Prior investigations of BBB transcytosis of proteins have employed conjugates of horseradish peroxidase (W) (4). However, HRP conjugates in brain may be difficult to detect histochemically owing to dilution of HRP molecules after transport into brain interstitial fluid. Application of colloidal gold complexes may improve the sensitivity. Colloidal gold conjugates with antibodies were previously used in pre-embedding or post-embedding protocols for electron microscopic studies of the BBB. They proved to be sensitive tools for the detection of BBB-specific proteins on endothelial cells (6) and pericytes (14). Other constituents of the BBB, such as anionic sites (26) and glycoproteins (19, 27, 28) were visualized with poly-Llysine-colloidal gold and various lectin-gold complexes, respectively. Albumin-gold complexes were used as a macromolecular tracer to study fluid-phase transport across the BBB in vitro (30) and in vivo in lesion models (29).
In the present study, a 5-nm colloidal gold conjugate of monoclonal antibody (MAb) OX26 was infused in vivo in rats to examine uptake at the BBB. We chose the mouse anti-rat transferrin receptor MAb OX26 as a model because several studies showed significant BBB passage of this antibody (1, 9, 10, 32) . OX26 and an IgGza isotype control mouse MAb, UPC10, were conjugated to 5-nm colloidal gold. The gold conjugates were used for in vivo brain perfusion experiments employing the techniques used in previous physiological and pharmacological studies (1,32). The brains were perfusion-fixed with 2% glutaraldehyde and prepared for light microscopy (LM) or electron microscopy (EM). The LM studies were facilitated by silver enhancement of gold particles.
Materials and Methods
Antibody-Gold Conjugates. The mouse IgG2, MAb OX26 was purified from ascites fluid produced in Balblc mice as described (32). The mouse myeloma protein UPClO was used as an IgG2, isotype control and was purified from cleared ascites (Cappel Organon Teknika, Durham, NC). OX26 and UPClO were conjugated to 5-MI colloidal gold (E-Y Laboratories; San Mateo, CA). The colloidal gold suspensions in 0.002 M borate buffer (pH 8.5-9) had IgG concentrations between 145 and 400 pglml. For the in vivo infusions, the following solutions were prepared. (a) OX26-colloidal gold (0x26-Au) was diluted with 0.25 M NaCl to give a final concentration of 40-58 pglml in 0.15 M NaCI. (b) Ten mlOX26-Au or UPClO colloidal gold (UPC10-Au) was brought to a final volume of 15 ml to obtain IgG concentrations of 267 pglml in Krebs-kenseleit buffer (final concentrations 118 mM NaCI, 4.7 mM KCI, 2.5 mM CaCl2, 1.2 mM MgS02, 1.2 mM KH2P04, 25 mM NaHCO3, 10 mM D-glucose) containing 1% bovine serum albumin (BSA), which was equilibrated with 95% 02/5% CO2 before brain perfusion (see below).
Perfusion with IgG-Gold and Preparation of Brain Tissue. Male Sprague-Dawley rats (Harlan; Indianapolis, IN) weighing 240-300 g were used. The rats were anesthetized with ketamine 100 mglkg and xylazine 2 mglkg IP. The animals were prepared for brain perfusion as described previously (25) . Briefly, the external carotid artery was retrogradely cannulated with a PE-10 catheter after the occipital, superior thyroid, and pterygopalatine arteries had been cauterized. Two different infusion protocols were used.
In Protocol A (low-dose infusion), the ipsilateral common carotid artery stayed open, and the IgG-colloidal gold solution (a) was infused into the external carotid artery at a rate of 0.18 mllmin for 10 min. Total amount of antibody infused was 72 pg and 104 pg/animal (n = 2). and the estimated arterial concentration of antibody was <5 pg/ml. At the end of the infusion a thoracotomy was performed. The ascending aorta was cannulated and the descending aorta was ligated. Both jugular veins and the right atrium were cut. Blood content was washed out from the tissue by perfusion with ice-cold %-buffered saline (10 mM Ek, pH 7.4) containing 0.1 mglml CaC12 until the effluent was clear (approximately 1 min). The tissue was perfusion-fixed with 250 ml2% glutaraldehyde (Ted Pella; Redding, CA) in the same buffer (15-20 min). Two control animals were perfusion-fixed in the same way with the omission of the gold infusion.
In Protocol B (high-dose perfusion), the ipsilateral common carotid artery was ligated immediately WOE a perfusion with 0x26-Au or UPC10-Au solution (b) was started at a rate of 1.25 mllmin for 10 min (n = 2 each).
Total amount of antibody infused was 3.3 mg/anhal, and the arterial antibody concentration was approximately 250 pglml. After 10 min the vasculature of the perfused hemisphere was cleared from the IgGAu sohtions with 5s-buffered saline (7.5 mllmin for 1 min) through the same catheter, and was then perfusion-fixed with 2% glutaraldehyde in Eisbuffered saline with 0.1 mg/ml CaC12 (20 min at 7.5 mllmin).
Tissue Processing for Light and Electron Microscopy. The fixed brains were removed from the skull and cut into Wl-mm coronal slices. Alternating slices were prepared for LM or EM. For LM, 30-pm coronal sections wre cut on a vibratome and floating sections were silver-enhanced for 20-30 min at room temperature (RT) with the IntenSE M reagent (Amenham; Arlington Heights, IL) according to the manufacturer's instructions as described previously (7.18) . The sections were air dried on glass slides and covenlipped.
Brain slices for EM were post-fixed in the same fixative used for perfusion for 4 hr at 4% and dehydrated in ethanol for embedding in Spurr.
Ultra-thin sections were cut and stained with uranyl acetate for EM examination with a JEM-100CX (JEOL; Tokyo, Japan).
Brain pezfusion with 1z51-labeled UPClO. UPClO was labeled with 1251 using a chloramine T protocol. Twenty pg (0.13 nmol) antibody was reacted with a fivefold molar excess of ['251 ]-Na (Amersham), and a 20-fold molar excess of chloramine T in a total volume of 40 pl0.2 M Na-phosphate buffer, pH 7.4. The reaction time was 1 min at RT, after which the labeling was stopped by the addition of 5 nM Na2S205. The labeled antibody was separated from free 12>1 by gel filtration on Sephadex G25 (0.7 x 28 cm) and was eluted with 0.02 M Na-phosphatelO.15 M NaCI, pH 7.4, containing 0.1% bovine serum albumin. The specific activity was calculated as 1977
Cilmmol. The precipitability of ['251 ]-LJPC10 with trichloroacetic acid was 99.5%. Fresh tracer was diluted to 1 pCilml in Krebs-Henseleit buffer containing 1% BSA and used for brain perfusions as described in Protocol B (n = 3). After 10-min tracer perfusion, the animals were decapitated and the brains were removed. The brain was weighed and the tissue processed for the measurement of brain uptake by the capillary depletion method as described by Triguero et al. (25) . Briefly. the tissue was homogenized in a 20% dextran solution and centrifuged (3500 x g, 15 min) to obtain a vascular pellet (capillary fraction) and a "capillary-depleted postvascular supernatant fraction. The d a r pellet contained tracer bound to or taken up by the brain capillaries, and the postvascular supernatant comprised intravascular content and tracer that has passed into brain tissue beyond the vascular wall. The brain volume of distribution (VD) of [ '2'I]-UPC10 in whole-brain homogenate and in the pellet and supernatant fractions was determined. The VD [pllg] was calculated as the ratio of concentration of radioactivity in the tissue fraction (dpm/g whole homogenate, pellet, or supernatant) and the perfusate tracer concentration (dpml pl).
Results
At the LM and EM level, both the low-dose and high-dose perfusion protocols gave qualitatively similar results. LM of the silverenhanced vibratome sections obtained after infusion (Protocol A) or perfusion (Protocol B) with 0x26-Au showed distinct labeling of the vascular tree in brain tissue ( Figures 1A and 1B) . The staining of the vascular wall ( Figure 1B) was not due to colloidal gold in residual perfusion fluid trapped inside the lumen. This can be concluded from the complete absence of erythrocytes in the brain vessels (Protocol A), indicating effkient clearing of the intravascular content by the buffer wash and perfusion-fixation. The silver reaction was specific for the presence of colloidal gold, as treatment of brain sections from the control rats that did not receive colloidal gold infusions gave no silver deposition. There was no silver deposition visible in tissue outside the vascular tree in excess of the very low background signal of the non-perfused contralateral hemisphere.
The main difference between the low-rate infusion (Protocol A) and the high-rate perfusion (Protocol B) was that the first gave a patchy regional distribution of the staining pattern in the VI V I F homolateral hemisphere on the coronal sections. In some regions staining was intense, whereas other parts on the same section were only weakly positive. The distribution of these staining patterns was preserved among sequential sections of the same brain. The brains perfused with Protocol B gave a homogeneous staining of the vasculature of the perfused hemisphere. In contrast to the naive control brains (no gold perfusion), the brains perfused with the control antibody, UPC1O-Au, showed a qualitatively similar staining pattern of brain capillaries as with 0x26-Au ( Figure IC) . However, the intensity of silver staining was less compared with the 0x26-Au-perfused brains.
EM examination of the samples revealed that 0x26-Au was bound to the luminal plasma membrane of endothelial cells (Figure 1E) . Multiple gold particles could be observed intracellularly, predominantly clustered in vesicular structures of 50-100 nm resembling endosomes ( Figure 1E ) or multivesicular bodies ( Figure ID) . Some gold particles could also be detected on the abluminal plasma membrane of the endothelial cells (Figure lD) , suggestive of exocytosis.
As could be expected from the LM result, examination of the UPC10-Au-perfused brains at the EM level revealed some vascular gold particles ( Figure 1F ). Most of them were in contact with the luminal endothelial surface, like the membrane-bound 0x26-Au. A few gold particles were observed within endothelial cells in small vesicular structures. However, in contrast to 0x26-Au they were not packed within the same vesicle but were isolated ( Figure 1F) . No gold could be detected in brain tissue beyond the endothelial cells after perfusion with UPClO-Au.
The brain perfusions with [ 12sI]-UPC10 showed a VD value for brain homogenate of 13.3 +. 1.6 pl/g (mean f SE). This value is not significantly different from the VD measured with the same brain perfusion method for intravascular markers such as albumin (25) or sucrose (32). The capillary-depletion analysis gave VD values of 0.24 f 0.05 pl/g for the vascular pellet and 12.0 * 1.3 pl/g for postvascular supernatant. This shows that there was virtually no binding or uptake of the UPClO tracer by vascular structures.
Discussion
The primary goal of this study was to test if an anti-transferrin receptor antibody conjugated with 5-nm colloidal gold could be detected in brain tissue after in vivo perfusion via the internal carotid artery. The in vivo receptor labeling was performed with a low-dose infusion and a high-dose perfusion protocol. It has been shown at the LM level with standard immunoperoxidase histochemistry that OX26 targets brain capillary endothelial cells after peripheral administration in rats (9,ii). Silver enhancement on vibratome sections in our study gave comparable results as reported in these studies.
The explanation for the failure to see silver deposits outside the vasculature at the LM level may be that the silver enhancement technique is not sensitive enough to detect the gold signal in the tissue. The sensitivity may be a crucial factor in the interpretation of apparently conflicting results of physiological studies using tracer techniques and morphological studies. In the case of transferrin uptake by brain, tracer experiments indicate the transcytosis of this protein through the BBB (8, 23) . Transferrin within the brain tis-sue appears to be localized predominantly in oligodendrocytes (>), but its origin from blood has not been proven. A recent morphological study could not provide evidence for transcytosis of transferrin through the BBB (20) . In this study, a conjugate to transferrin with horseradish peroxidase (Tf-HRP) was perfused in rats post mortem, which were then perfusion-fixed. EM examination failed to detect any reaction product (diaminobenzidine) at the abluminal plasma membrane of brain capillary endothelial cells or beyond, although a recycling endocytic pathway at the luminal side and within the endothelial cells was described. This result was interpreted as the absence of transferrin transcytosis. However, an alternative explanation may be that the large dilution that occurs in brain tissue may have prevented the detection of the HRP sig nal. This can be easily illustrated by comparing the size of the intraendothelial volume of approximately 0.8 pllg brain (17) and the extracellular space in brain tissue of approximately 19 vol% or approximately 200 pl/g brain (15). Therefore, after leaving the endothelial cell any tracer is diluted at least 200-fold. If the tracer has access to other brain cells, the dilution factor is even larger. The use of colloidal gold as a marker should improve the morphological detectability of tracers in brain tissue even after such high dilutions, because in theory each single gold partide can be detected. The described visualization of abluminal gold ( Figure ID) may be a first confirmation of this theoretical consideration. However, for a reliable quantitative analysis with the presented approach, the evaluation of many EM sections will be required. One improvement might be the application of thicker sections and high-voltage EM.
The comparison of the low flow-rate infusion and the perfusion protocols showed that the latter may be preferable. The patchy staining obtained with the low-flow infusion may be explained by intravascular streaming at low flow rates, leading to inhomogeneous distribution in the vascular bed (21). On the other hand, the higher dose of 0x26-Au administered with Protocol B did not lead to an apparent increase of endothelial uptake of the same magnitude (>30-fold difference of the doses), indicating saturation of the BBB transferrin receptors.
Further studies are required to determine the potential influence of the colloidal gold on the brain uptake of OX26 in this experimental setting. Colloidal gold conjugate (18-nm diameter) have been successfully used to demonstrate endothelial transferrin transcytosis in the bone mauow (24) and the liver (13). However, changes in the intracellular pathway of transfefrin (16) and an anti-uansferrin receptor antibody (12) after gold conjugation to 8-or 9-nm colloids have also been described. With regard to endothelial binding and endocytosis observed with the UPC10-Au conjugate (Figure lC) , the negative result of the tracer uptake study using [ 12sI]-UPC10 makes it unlikely that this could be due to specific binding of the UPClO antibody. Moreover, the known antigen of UPClO is a bacterial levan (31), and no affinity to endothelial cells has been described. A possible explanation for the silver enhancement of brain vessels after perfusion with UPC10-Au ( Figure IC) could be the presence of scavenger receptors on brain endothelial cells, which are able to bind proteins conformationally modified by gold conjugation. Such a mechanism has recently been described for an albumin-5-nm gold colloid (22) . The scavenger receptor is present at the BBB and causes selective receptor-mediated endocytosis of blood-borne ligand by the brain capillary endothelium (25). It is not known if very small gold colloids (1-2 nm)would have the same effect. However, the use of gold colloids smaller than I nm would require the application of silver enhancement also at the EM level (7).
In conclusion, the present results show the feasibility of the internal carotid artery infusion technique, as established in physiological tracer studies, for morphological applications to examine BBB transport. This approach can be used in future evaluations of in vivo receptor labeling with gold conjugates for studying BBB transcytosis at the ultrastructural level.
